特发性声带突肉芽肿的管理:喉科医师学术调查
本研究通过21题问卷调查美国168名学术机构喉科医师对特发性声带突肉芽肿的临床决策与结局,共分析106份回复,完成率63.1%。病因最常归因于嗓音创伤(96.2%)和反流(71.8%),一线治疗最常用抗反流药物(92%),其次为嗓音治疗(58.8%)和吸入性激素(42.5%),68.4%的医师报告复发不常见,发音障碍是最常见长期后遗症(27.8%)。作者认为抗反流药物和嗓音治疗可能为最广泛使用且最有效的治疗选择,并需进一步研究建立金标准治疗。
要点
- 病因最常归因于嗓音创伤(96.2%)和反流(71.8%)。
- 一线治疗最常用抗反流药物(92%),其次嗓音治疗(58.8%)和吸入性激素(42.5%)。
- 68.4%的医师报告复发不常见,发音障碍为最常见长期后遗症(27.8%)。
核心结论
- 特发性声带突肉芽肿的治疗策略在美国仍存争议,基于调查结果,抗反流药物和嗓音治疗可能是最广泛使用且最有效的治疗选择。
- 作者建议应探索建立声带突肉芽肿的金标准治疗,并进一步研究抗反流和嗓音治疗后的复发或持续病例。
研究设计与样本
- 通过21题问卷对美国学术机构168名喉科医师进行调查,共分析106份回复,完成率63.1%,数据经Qualtrics平台分析。
主要发现
- 病因最常归因于嗓音创伤(96.2%)和反流(71.8%)。
- 一线治疗最常用抗反流药物(92%),其他常用一线治疗包括嗓音治疗(58.8%)和吸入性激素(42.5%)。
- 多数喉科医师报告复发不常见(68.4%)。
- 发音障碍是最常见长期后遗症,占27.8%。
临床怎么用
- 基于调查结果,抗反流药物和嗓音治疗可能是最广泛使用且最有效的治疗选择。
- 作者建议应探索建立声带突肉芽肿的金标准治疗,并进一步研究抗反流和嗓音治疗后的复发或持续病例。
局限性
- 证据等级为5。
- 作者指出需进一步研究抗反流和嗓音治疗后的复发或持续声带突肉芽肿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Vocal process granulomas (VPGs) are benign laryngeal lesions that may manifest as ulcerated regions of the vocal fold or nodular polypoid lesions. Gold standard treatments for idiopathic VPG are yet to be established at this time. This study evaluated clinical decision-making and outcomes in the treatment of VPG patients based on experiences of academic laryngologists across the United States. METHODS: A 21-question survey was developed to evaluate each respondent's specific VPG patient population, clinical decision-making in treating VPG, and corresponding treatment outcomes. The survey was distributed to 168 laryngologists at academic institutions across the United States. Data were analyzed through the Qualtrics platform. RESULTS: A total of 106 responses were analyzed, with a completion rate of 63.1%. Etiology of VPG was most commonly attributed to phonotrauma (96.2%) and reflux (71.8%). Primary first-line treatment was most commonly antireflux medications (92%). Other common first line treatments included voice therapy (58.8%) and inhaled steroids (42.5%). With these treatments, the majority of laryngologists report that recurrence is uncommon (68.4%). Dysphonia was cited as the most frequent long-term sequelae at 27.8%. CONCLUSIONS: VPG treatment strategies continue to be controversial across the United States with many treatments described in the literature with variable application in the practice of academic laryngologists today. Based on survey results, antireflux medications and voice therapy may be the most widely used and most effective treatment options. Establishment of gold standard therapy for VPG as well as further research into recurrent or persistent VPG despite antireflux and voice therapy should be explored. LEVEL OF EVIDENCE: 5 Laryngoscope, 134:795-802, 2024.
引用
- Boyce C, Schmidt KL, Gilbert MR, et al. Management of Idiopathic Vocal Process Granuloma: A Survey of Academic Laryngologists. Laryngoscope. 2023. PMID: 37602761. doi:10.1002/lary.30976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。